Journal of Cystic Fibrosis
Volume 9, Issue 2 , Pages 110-116 , March 2010

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis

  • Christopher R. Sudfeld

      Affiliations

    • The Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, 615 N. Wolfe Street, 6th Floor, Baltimore, MD 21205, United States
    • Corresponding Author InformationCorresponding author. 615 N Wolfe Street, 6th Floor, Baltimore, MD 21205, United States.
    • ,
  • Elliott C. Dasenbrook

      Affiliations

    • The Johns Hopkins University School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine, 1830 E. Monument Street, 5th Floor, Baltimore, MD 21205, United States
    • ,
  • William G. Merz

      Affiliations

    • The Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, 615 N. Wolfe Street, 6th Floor, Baltimore, MD 21205, United States
    • The Johns Hopkins Medical Institutions, Department of Pathology, Division of Microbiology, 600 N. Wolfe S, Meyer B1-193, Baltimore, MD 21287, United States
    • ,
  • Karen C. Carroll

      Affiliations

    • The Johns Hopkins Medical Institutions, Department of Pathology, Division of Microbiology, 600 N. Wolfe S, Meyer B1-193, Baltimore, MD 21287, United States
    • ,
  • Michael P. Boyle

      Affiliations

    • The Johns Hopkins University School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine, 1830 E. Monument Street, 5th Floor, Baltimore, MD 21205, United States

Received 3 October 2009 ,Revised 29 November 2009 ,Accepted 30 November 2009.

References 

  1. Fries MH, Bashford M, Nunes M. Implementing prenatal screening for cystic fibrosis in routine obstetric practice. Am J Obstet Gynecol. 2005;192:527–534
  2. Brennan AL, Geddes DM. Cystic fibrosis. Curr Opin Infect Dis. 2002;15(2):175–182
  3. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918–951
  4. Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis. 2001;183(3):444–452
  5. Cystic Fibrosis Foundation Patient Registry. 2001 Annual Data Report to the Center Directors. Bethesda, MD: Cystic Fibrosis Foundation; 2002;
  6. Bakare N, Rickerts V, Bargon J, et al. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses. 2003;46(1–2):19–23
  7. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in cystic fibrosis patients. Chest. Jun 30 2009;Epub ahead of print
  8. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–187
  9. Wang X, Dockery DW, Wypij D, et al. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol. 1993;15(2):75–88
  10. Vittinghoff E, Shiboski SC, Glidden DV, et al. Regression methods in biostatistics: linear, logistic, survival, and repeated measures models. New York: Springer; 2005;
  11. Elborn JS. Identification and management of unusual pathogens in cystic fibrosis. J R Soc Med. 2008;101:2–5
  12. Nagano Y, Millar BC, Johnson E, Goldsmith CE, Elborn JS, Rendall J, et al. Fungal infections in patients with cystic fibrosis. Rev Med Micro. 2007;18(1):11–16
  13. Shoseyov D, Brownlee KG, Conway SP, et al. Aspergillus bronchitis in cystic fibrosis. Chest. 2006;130(1):222–226
  14. Hutcheson PS, Knutsen AP, Rejent AJ, et al. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest. 1996;110(2):363–366
  15. Lambiase A, Raia V, Del Pezzo M, et al. Microbiology of airway disease in a cohort of patients with cystic fibrosis. BMC Infect Dis. 2006;6:4
  16. Pihet M, Carrere J, Cimon B, et al. Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis — a review. Med Mycol. 2008;23:1–11
  17. Burns JL, Emerson J, Stapp JR, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27(1):158–163
  18. Samarakoon P. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis. 2008;5(1):19–27
  19. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med. 2006;173(7):707–717
  20. Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 1991;6(1):15–20
  21. Ritz N, Ammann RA, Casaulta Aebischer C, et al. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis. Eur J Pediatr. 2005;164(9):577–582
  22. Ren CL, Pasta DJ, Rasouliyan L, et al. Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis. J Pediatr. 2008;153(6):746–751
  23. Schmidt J, Davidson AGF, Seear M, et al. Is the acquisition of Pseudomonads in cystic fibrosis patients increased by use of inhaled corticosteroids? Unexpected results from a double blind placebo controlled study. Pediatr Pulmonol. 1997;(Suppl 14):293–294
  24. Minicucci L, Severi G, Cresta L, et al. Impact of inhaled corticosteroids on the risk of early Pseudomonas aeruginosa acquisition in cystic fibrosis. Acta Paediatr. 2003;92:684–687
  25. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis—state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis. 2003 Oct 1;37(Suppl 3):S225–S264
  26. Gondor M, Michaels MG, Finder JD. Non-aspergillus allergic bronchopulmonary mycosis in a pediatric patient with cystic fibrosis. Pediatrics. 1998;102(6):1480–1482
  27. Nagano Y, Millar BC, Goldsmith CE, et al. Emergence of Scedosporium apiospermum in patients with cystic fibrosis. Arch Dis Child. 2007;92(7):607

PII: S1569-1993(09)00157-X

doi: 10.1016/j.jcf.2009.11.010

Journal of Cystic Fibrosis
Volume 9, Issue 2 , Pages 110-116 , March 2010

Article Tools

* Image Usage & Resolution